BIOGEN for BIOGEN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
1) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement; and 2) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the US-EU (TTIP) trade agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND | Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy |
| ALLY MARIE MENDENHALL | Legislative Assistant, Sen. Mike Johanns (NE) |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Taxation/Internal Revenue Code TAX
1) Support domestic and international tax policies which protect and incentivize US-based research and manufacturing jobs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND | Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy |
| ALLY MARIE MENDENHALL | Legislative Assistant, Sen. Mike Johanns (NE) |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Copyright/Patent/Trademark CPT
1) Innovation Act (H.R. 9) and the Patent Transparency and Improvements Act promoting appropriate rules for discovery and pleadings in patent cases for both drugs and biologics; and 2) support changes to Inter Partes Review process within the Patent & Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND | Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy |
| ALLY MARIE MENDENHALL | Legislative Assistant, Sen. Mike Johanns (NE) |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Health Issues HCR
1) Support 340B anti-fraud and program integrity policies; 2) Support policies to improve National Newborn Screening Program, including H.R. 1281 and S. 1417; 3) ACA implementation oversight to protect patient access to medical specialists in new health care insurance exchanges; 4) support efforts to modernize FDA processes in the 21st Century Cures initiative; and 5) Opposition to the Medical Innovation Act (S. 320/H.R. 744).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND | Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy |
| ALLY MARIE MENDENHALL | Legislative Assistant, Sen. Mike Johanns (NE) |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Medicare/Medicaid MMM
1) Opposition to rebates price controls in the Medicare Part D program; and 2) Opposition to changes in the Medicare Part B reimbursement system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND | Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy |
| ALLY MARIE MENDENHALL | Legislative Assistant, Sen. Mike Johanns (NE) |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.